Autopsy report · NCT04181255

Cold Heart Study: A Randomized Pilot Trial of Surfactant Therapy

“Investigator Retirement”

The sponsor’s own words in the registry.

Life of this trial

• Registered 3 months before it started.
• Ran for about 4 months before it stopped.
• 2 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Phase 1

Sponsor

University of Michigan

Sponsor type

University, hospital or other

Conditions

Congenital Heart Disease; Hypoplastic Left Heart Syndrome

Interventions

Curosurf; Sham

Participants

2

Sites

1

Countries

United States

Trials that died the same way

• Nutraceuticals Versus Usual Care in the Prevention or Reduction of CIPN in Patients Treated With Docetaxel as Neoadjuvant/Adjuvant Breast Cancer Therapy
  “Retirement of the Principal Investigator” (87% match in meaning)
• Trial of Art Therapy During Cognitive Processing Therapy for PTSD
  “Investigator has retired.” (83% match in meaning)
• Pharmacogenomic Testing in Major Depressive Disorder
  “Investigator retired.” (82% match in meaning)
• An Imaging Study of [18]F-fluoro-3'-Deoxy-3'-L-fluorothymidine ([18]F-FLT) in Patients With Locally Advanced or Metastatic Pancreatic Cancer Who Will be Treated With Gemcitabine or Other Nucleoside Analogs
  “Retirement of former Qualified Investigator and lack of resources to complete study” (79% match in meaning)
• HCV Treatment With Fluvastatin, Simvastatin to Improve Interferon Sensitivity
  “Principal Investigator retiring” (76% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.